I. Introduction
Estrogen receptor a (ERa) is a member of the nuclear receptor superfamily and a ligand-dependent transcriptional factor mediating the physiological effects of estrogens [22] . ERas are distributed in many tissues and organs; reproductive tissues [17] , cardiovascular system [47] , skeletal tissues [30] and central nervous system [24, 52] .
The subcellular localization of steroid hormone receptors has been examined using various procedures including receptor autoradiography, immunohistochemistry and cell fractionation. Recently, intracellular trafficking of steroid hormone receptors was studied using the green fluorescent protein (GFP) in living cells showing that unoccupied glucocorticoid receptors (GRs) [18, 35, 37] and androgen receptors [12] are mainly cytoplasmic, whereas mineralocorticoid receptors [9, 34] and progesterone receptors [31] are both in the cytoplasm and nucleus, following rapid nuclear accumulation after occupation with ligands.
It had been accepted in the 1970s that the unliganded ERa was in the cytoplasm and was translocated to the nucleus on binding to ligands via cell fractionation of the homogenated contents [11, 13] . When immunocytochemical techniques became available, it was confirmed that ERa is localized in the nuclear compartment [25, 53] . Immunoelectron microscopic studies [8, 14, 50, 53] , cytochalasin B-induced enucleation procedures [49] and recent studies in living cells derived from human epithelial cell lines tagged with GFP [19] supported the nuclear localization of ERa. However, some studies showed the low but significant cytoplasmic ERa-immunoreactivity (IR) observed in various tissues [1, 10, 23] . One study on human breast cancerCorrespondence to: Mitsuhiro Kawata, Department of Anatomy and Neurobiology, Kyoto Prefectural University of Medicine, KawaramachiHirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. derived cells, MCF-7, presented that approximately 15% of the ERa were retained in the cytoplasm in each cell using a cell enucleation method [48] .
Intranuclear distribution of ERa has remained controversial. The transition of the hormonal milieu with ovariectomy [46] or estradiol (E2) treatment [8] caused no significant differences in ultrastructural localization of ERa-IR in in vivo reproductive and non-reproductive cells using immunoelectron microscopy, whereas redistribution of ERa was reported in the case of cell lines visualized with GFP and its variants after ligand treatment [19, 44] . The compartmentalization of ERa in the nucleus has been studied by immunoelectron microscopy showing ERa-IR with a speckled pattern [53] in the dispersed euchromatin [14] , in the margin of the condensed chromatin [50] and in the interchromatin space [8, 46] .
In the present study, we investigated the time-lapse imaging of subcellular localization of GFP-ERa in living COS-1 cells which do not contain endogenous steroid hormone receptors using a fluorescent microscope, and, in addition, the subnuclear distribution using a confocal laser scan microscope including the time-course study. We treated the transiently transfected cells with the physiological ERa agonist, E 2 [42] , or the synthetic partial antagonist, tamoxifen (Tam) [15] to clarify whether the receptor was redistributed in the nucleus of a single cell after ligand treatment. We also used immunocytochemistry to confirm the subcellular localization of ERa not only in the transfected COS-1 cells but also in the Ishikawa cells derived from human uterine [36] and MCF-7 cells derived from human breast cancer [2] , both of which express endogenous steroid hormone receptors. We present here that GFP-ERa is distributed in the nucleus in single COS-1 cell in living state in the same manner as ERa-immunoreactivity in fixed cells and accumulated regardless of ligand milieu.
II. Materials and Methods

Plasmid construction of pEGFP-C1-ER6
The pEGFP-C1 plasmid (Clontech, Palo Alto, CA, USA) encodes the GFPmut1 variant [5] encoding a redshifted variant of wild-type GFP with the double-amino-acid substitution of Phe-64 to Leu and Ser-65 to Thr. Expression is driven from a cytomegalovirus promoter. Rat ERa (rERa) cDNA was isolated from PUC-ER6 [27] (from Dr. Koike S. and Dr. Muramatsu M., Dept. of Biochemistry, Faculty of Medicine, University of Tokyo, Saitama Medical School, Japan) by Bbe I-EcoR I digestion with blunt end formation and inserted at the Sma I site in multiple clone sites of pEGFP-C1 (Fig. 1) . The C terminus of EGFP was coupled to the 59th amino acid position of the N terminus of rERa, resulting in 88 kDa of fusion protein.
Cell culture and transfection
COS-1 cells were maintained in Dulbeccco's modified Eagle's medium (DMEM) (Gibco BRL, CergyPontoise, France) supplemented with 10% fetal calf serum (FCS) and kanamycin. For transfection, semiconfluent cells were resuspended at 2´10 4 cells in DMEM into each well of a Multidish (Nunc, Naperville, IL, USA) for fluorescence microscopy analysis, and at 1.6´10 4 cells onto the glass at the bottom of the Glass-bottom dish (MATSUNAMI, Osaka, Japan) for confocal laser scan microscopy analysis. Cells were grown for 24 hr, and transfected by LIPOFECTAMINE PLUS reagent (Gibco BRL) following the manufacturer's protocols with some modification using 300 ng of the pEGFP-C1-ER6 or pEGFP-C1 plasmid for the Multidish and 115 ng for the Glass-bottom dish per well for 5 hr at 37°C. After removing the DNA medium, cells were incubated for 4 hr with OPTI-MEM I (Gibco BRL) containing 10% charcoal-stripped FCS. The medium was then replaced and cells were grown with OPTI-MEM I without serum for 12-18 hr until imaging.
Characterization of GFP-ERa
Immunocytochemistry of COS-1 cells with anti-GFP or antiERa antibody
COS-1 cells transfected with pEGFP-C1-ER6 or pEGFP-C1 were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) at pH 7.4 for 10 min at 37°C. The fixed cells were incubated in the PBS containing 0.2% Triton X-100 and 2% bovine serum albumin to permeabilize and prevent nonspecific staining for 60 min at room temperature (RT). Cells were subsequently incubated with the monoclonal anti-GFP antibody produced by mouse hybridoma cells (Clontech) diluted to 1:3,000 or the polyclonal anti-rat ERa antibody raised in a rabbit (AS409, from Dr. Hayashi S., Yokohama City University, Faculty of Science, Japan) [38] diluted to 1:2,000 with PBS for 40 hr at 4°C. They were further incubated with the biotinylated goat antimouse or anti-rabbit IgG (7.5 mg/ml; Vector Laboratories, Western blot analysis COS-1 cells were resuspended at 2.5´10 5 cells per 2 ml in DMEM into the dishes (FALCON, Franklin Lakes, NJ, USA) and transfected with 1.44 mg of pEGFP-C1-ER6 or pEGFP-C1. Cells were solubilized in 500 ml of 3´sample buffer (195 mM Tris-HCl, pH 6.8, 9.156% SDS, 15% 2-mercaptoethanol, 30% glycerol, 0.0075% bromophenol blue). Proteins were denatured by boiling for 5 min, separated via SDS/12.5% PAGE and transferred to polyvinylidene difluoride membrane (Immunobilon-P, Millipore, Bedford, MA, USA). Blots were blocked in 2.5% skimmed milk (DIFCO, Detroit, MI, USA) in Tris buffered saline-polyoxyethylene sorbitan monolaurate (Tween 20) (TBST; 0.02 M Tris, 1.5 M NaCl, 0.05% Tween-20, pH 7.6) for 90 min followed by antibody incubation with anti-GFP serum diluted to 1:3,000 and anti-ERa serum (AS409) diluted to 1:2,000 for 20 hr at 4°C. After washing with TBST, membranes were incubated with horseradish peroxidase-linked secondary antibody diluted to 1:5,000 with TBST for 1 hr at RT. An enhanced chemiluminescence detection technique (Amersham, le Ulis, France) was used.
Transcription regulation study
COS-1 cells were seeded at 1.0´10 5 cells per 2 ml in DMEM into the dishes (FALCON). The reporter plasmid, estrogen response element (ERE)-G-Luc (from Maruyama K., Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Japan) [32] , has the construction as below; Rabbit b-globin TATA box (-40 to +10) was introduced into the upstream region of the luciferase gene of the pGL2-basic vector (Promega, Madison, WI, USA), and a palindromic estrogen responsive element (ERE, AGGTCACAGTGACCT) was fused upstream from the TATA box. Cells were transfected with 1 mg of each pEGFP-C1-ER6, ERE-G-Luc and pCH110, a b-galactosidase reporter (Pharmacia, Uppsala, Sweden). After removing the DNA medium, cells were incubated for 4 hr with OPTI-MEM I containing 10% DCC-FCS and then containing 2% DCC-FCS. After 12 hr, cells were washed and replaced with fresh OPTI-MEM I without serum with or without 1 mM E2. After 24 hr, cells were lysed to determine luciferase and b-galactosidase activity by PicaGene Reporterlysis Buffer (Toyo Inki, Tokyo, Japan). For luciferase activity, the extracts were assayed with a New Reporter Gene Luciferase Assay System PicaGene kit (Toyo Inki) and were normalized to the b-galactosidase activity analyzed with a Luminescent bgalactosidase Detection Kit (Clontech) following the manufacturer's protocols.
Fluorescence microscopy analysis
Transfected cells were treated with either 1 nM E 2 or 50 nM Tam, at approximately ten-fold higher concentrations than the dissociation constant of ERa for each ligand [29] , and the images of identical cells were acquired before and 60 min after treatment. Cells were soaked in 300 ng/ml bisbenzimide (Hoechst No. 33342, Sigma, St. Louis, MO, USA) to visualize nuclei and then observed with a 40´ objective lens. GFP fluorescence was viewed by excitation with transmission through a 460-to 490-nm band pass filter and an emission peak transmission at the 515-nm line. The fluorescence from the staining with Hoechst 33342 was observed using the excitation filter with the transmission through a 330-to 385-nm band pass filter and an emission peak at 420 nm. Fluorescence images were acquired on a SenSys 1400 high-resolution, cooled charge-coupled device (CCD) camera (Photometrics, Tucson, AZ, USA) attached to the fluorescence microscope (IX70, Olympus, Tokyo, Japan) set in the dark room kept at 37°C during analysis, as described in detail previously [35] . Images were evaluated using IPLab Spectrum software (Signal Analytics Corporation, Vienna, Austria).
Time-lapse confocal laser scan microscopy analysis
Transfected COS-1 cells were treated with either 1 nM E 2 or 50 nM Tam. Just before and 60 min after treatment with ligands, they were imaged through a 60´1.4 numerical aperture Plan Apochromat oil immersion objective attached to an inverted microscope (ECLIPSE TE300, Nikon, Tokyo, Japan) by excitation with a 488-nm line from a kryptonargon laser, and the emission was viewed through a 500-nm long pass filter. Images were collected with Radiance 2000 (Bio-Rad, Hercules, CA, USA) using LaserSharp 2000 software (Bio-Rad). For the time course analysis, images were captured every 10 or 15 min for 60 min after ligand treatment. The analyses of the images from the confocal laser scan microscope were performed using NIH Image program version 1.61. To obtain line graphs, pixel values for each area along the lines of major or minor axes scanned on the captured cells were divided.
Immunocytochemistry of Ishikawa cells and MCF-7 cells with anti-ERa antibody
Ishikawa cells and MCF-7 cells were maintained in modified Eagle's medium (MEM) (Biken, Osaka, Japan) supplemented with 10% fetal calf serum (FCS) and Antibiotic-Antimycotic (Gibco BRL). Cells were fixed and immunostained with the anti-rat ERa antibody (AS409) diluted to 1:1,000. The same procedure was performed with the COS-1 cells. Other dishes of each kind of cells were omitted from the reaction with anti-rat ERa antibody serum for the negative control.
III. Results
Characterization of GFP-ERa Immunocytochemistry of COS-1 cells with anti-GFP or antiERa antibody
The immunocytochemistry findings with anti-GFP antibody demonstrated both cytoplasmic and nucleoplasmic IRs in COS-1 cells transfected with pEGFP-C1 alone (Fig. 2Ab) , whereas dense nuclear labelings, except nucleoli, were seen in the pEGFP-C1-ER6-transfected cells (Fig.   2Ac ). COS-1 cells transfected with pEGFP-C1 alone did not show any ERa-labeling (Fig. 2Ae) , and in the cells expressing GFP-ERa, ERa-IR was detected only in the nuclei, not in the cytoplasm (Fig. 2Af) . In the nucleus, ERa-IR was not present in the nucleoli. Cells without transfection showed no GFP- (Fig. 2Aa) or ERa-IR (Fig. 2Ad) .
Western blot
Western blot analysis employing the anti-GFP antibody and anti-ERa antibody exhibited a major band at the posi- tion of the expected molecular mass, 88 kDa, on the lanes blotted with the GFP-ERa chimera protein expressed in the COS-1 cells (Fig. 2B lanes 2 and 4) . The cells transfected with pEGFP-C1 showed the band at the 27 kDa site representing EGFP with the anti-GFP antibody (the band of EGFP is out of the section of lane 1 shown in Fig. 2B ), but no bands were detected at the 88 kDa-site with anti-GFP or anti-ERa antibody (Fig. 2B lane 1, 3) .
Transcription regulation study PEGFP-C1-ER6 expressing the GFP-ERa chimera protein, plasmid ERE-G-Luc and pCH110 for normalization using b-gal activity, were cotransfected into COS-1 cells. Ligand-dependent induction of the ERE was 2-fold greater than the noninduced relative luciferase activity by GFP-ERa (Fig. 2C) . We confirmed that the transcriptional activation of the GFP-ERa chimera protein was functionally maintained despite the presence of GFP.
Fluorescence microscopy with a cooled CCD camera
We examined pEGFP-C1-ER6-transfected samples for subcellular distribution of the GFP-ERa chimera protein comparing with the localization of the GFP protein using pEGFP-C1-transfected cells. A cell expressing GFP alone exhibited green fluorescence in both the nucleus and cytoplasm (Fig. 3Ab) , whereas diffuse GFP-ERa fluorescence constituting fine particles was restricted to the nucleus, except the nucleoli, of transfected cells (Fig. 3Bc) . The region of nucleus was confirmed by Hoechst 33342 staining (Fig.  3Bb) . To investigate the ligand-inducible nucleocytoplasmic trafficking, we imaged the cells expressing GFP-ERa before and 60 min after adding 1 nM agonist E 2 in a single living cell. Sixty minutes after E 2 treatment, GFP-ERa remained in the nucleus (Fig. 3Bf ). We applied 50 nM partial antagonist, Tam, to the cells expressing GFP-ERa, and no apparent translocation of the fluorescence from the nucleus to the cytoplasm was observed as shown in the case of E2 treatment. A 100-fold higher concentration of ligands, 10 nM E 2 or 5 mM Tam was applied to transfected cells, but trafficking of GFP-ERa was not observed (data not shown).
Time-lapse confocal laser scanning microscopy
Transfected COS-1 cells were subjected to time-lapse imaging using a confocal laser scanning microscope to investigate spatiotemporal subnuclear distribution of GFPERa. Before the exposure to ligands, green fluorescence was found diffusely in a fine-grained distribution in the nucleus, except in the nucleoli (Fig. 4A, 0 min, Fig. 5A , 0 min). However, the size or the intensity of the fine speckles did not show complete uniformity in individual cells (data not shown). Incubation with 1 nM E 2 induced more punctate features of green fluorescence in a time dependent manner (Fig.  4A, 10 , 25, 40, 50 min). Sixty min after E2 addition, GFPERa was redistributed in the nucleus to form small clusters with more discrete accumulation, except in the nucleoli, than in the absence of E 2 (Fig. 4A, 60 min) . We traced the pixel values for fluorescence intensity along the lines from left to right or top to bottom settled as major or minor axes on images of the single cell at the time before and 60 min after E2 treatment (Fig. 4A line a-d) and constructed line graphs to analyze the ligand-induced subnuclear localization change of GFP-ERa (Fig. 4B) . The pixel values of the lines on the cell (Fig. 4A line a, b) shaped the transition pattern with a small and rather uniform amplitude in the untreated nucleus (Fig. 4Bab) . Sixty min after the treatment, the fluorescent intensity along the lines (Fig. 4A line c, d ) robustly changed with the greatest magnitude reflecting the punctate distribution of GFP-ERa (Fig. 4Bcd) . We also exposed the cells to 50 nM Tam to examine the subnuclear redistribution of GFP-ERa using the same procedure as in the case of E 2 and analyzed the images before and 60 min after the Tam treatment (Fig. 5A) . Cells formed the prominent speckles of green fluorescence in the nuclear region compared to the absence of Tam (Fig. 5A, 60 min) . The transition feature of the fluorescent intensity along the traced lines in the cells 60 min after Tam treatment (Fig. 5A line c, d ) presented more intensely up-and-down transition (Fig. 5Bcd ) than before treatment (Fig. 5Bab ) along the lines a and b (Fig. 5A) . These transformations mirrored the conspicuous change to a more punctated redistribution. The pixel value was markedly lowered in the region of the nucleoli and recovered outside the nucleoli (Fig. 5B) . It was unclear whether the subnuclear redistribution pattern of GFP-ERa was different between the kind of ligands, E 2 and Tam (Fig. 4A,  60 min, Fig. 5A , 60 min). 
Immunocytochemistry of Ishikawa cells and MCF-7 cells with anti-ERa antibody
Specific nuclear staining for ERa-IR was restricted within the nuclei and cytoplasmic staining was absent in both Ishikawa cells (Fig. 6 ) and MCF-7 cells containing endogenous ERa. The distribution features of ERa-IR in Ishikawa cells and MCF-7 cells were the same as those observed in the COS-1 cells. In contrast, ERa immunostaining was not shown in cells without incubation with anti-ERa serum.
IV. Discussion
Intracellular distribution of ERa has been investigated using diverse procedures which showed different results depending on the methods; cytoplasmic distribution of unliganded receptor with nuclear translocation after adding ligands [11, 13] , and cytoplasmic recognition with nuclear dominance [1, 10, 23] , although the idea of the restriction in the nucleus is now most widely accepted [8, 14, 25, 50, 53] . In this study, we presented the nuclear localization of ERa with immunocytochemical procedure in fixed cells expressing endogenous ERa, Ishikawa cells derived from human endometrial adenocarcinoma [36] and MCF-7 cells from human breast carcinoma [2] . Special features on the performance of each method could explain the discrepancies. The method of cell fractionation requires homogenization, which may have induced the finding that unliganded ERa was loosely associated with the nuclear matrix detected in the cytosol fraction, but liganded ERa was detected in the nuclear fraction with the tight association [14] . Immunoreactive techniques require many steps and long periods for reactions. Buchenau et al. [3] presented striking differences in the distribution of heterogeneous nuclear ribonucleoprotein (hnRNP) K protein, one of the proteins composing hnRNP complexes [28] , of living cells compared with fixed preparations. This inconsistency is considered to be caused by the changes of the chromatin structure, the change of the association with transcription sites by fixation, or the flexibility of transcriptional sites in living cells. Some nuclear receptors were depicted in a dissimilar nucleocytoplasmic distribution; progesterone receptor- [16] and thyroid receptor-IR [40] were detected in nuclei alone, whereas their fusion protein with GFP were found not only in the nuclei but also in the cytoplasm in certain ratios [31, 54] . We investigated the subcellular and subnuclear distribution using GFP fusion protein because GFP enabled visualization in a single living cell without fixation and permeabilization. The properties of the GFP-ERa chimera protein were confirmed with immunocytochemistry, western blot analysis and a transcription regulation study. The cells were not deteriorated during the entire course of microscopic observation.
The present findings showed that GFP-ERa chimera protein was localized in the nucleus even in the absence of ligands. Nucleocytoplasmic transport of proteins larger than 45 kDa is regulated through the nuclear pore complex by recognizing nuclear localization signals (NLS) [21] . A number of proteins possessing NLSs are predominantly cytoplasmic due to the inaccessibility or masking of their NLSs, which interact with other proteins or induce conformational change to translocate the proteins to the nucleus [21] . ERa owns four motifs of NLSs; a ligand-inducible NLS is in region E (hormone binding domain), and the other three are in region C (DNA binding domain) and region D. These NLSs, except for the ligand-inducible one, are not masked in the absence of ligands [51] , which supports the finding in the present investigation of the nuclear restriction of GFP-ERa.
GFP-ERa formed fine speckles in the absence of ligands and small clusters in the presence of ligands in the present study. The constituent of ERa-containing structures within the nuclei is one of the major topics of this area. It has been shown that ERa was localized in the chromatin in several immunoelectron microscopy studies, although its specificity in the chromatin, in the euchromatin [14] or in the margin of the condensed chromatin [50] , has not been clarified. Another study reported its detection in the interchromatin space [46] , which suggests the participation of certain protein factors in the nuclear matrix. HnRNP is one of the candidates composing the compound of ERa in the nuclei [46] . More than 20 different proteins are involved in hnRNP complex [28] ; some of the components were revealed by dotted nucleoplasmic staining, excluding the nucleoli [3, 7, 33] . Further more, previous studies reported the relation between ERa and protein complexes in the nuclei, such as SWI2/SNF2 [4, 20] . This complex is one of the proteins of the SWI/SNF complex facilitating the binding of activator proteins to nucleosomal DNA in an ATP-dependent way [6] and helping the transcriptional activator to overcome chromatin-mediated repression [26] . Confocal microscopic observation of the SWI/SNF complex revealed a diffuse nucleoplasmic labeling and a variable number of bright dots or foci [41] . The studies on the distributions of hnRNP and SWI2/SNF2 support the present findings of reticular or punctate nuclear signals of GFP-ERa. Considering the coexistence or interaction with chromatin, hnRNP or SWI2/ SNF2, fine or dotted accumulation of ERa in the nuclei, may be actively engaged in the transcriptional function of the nuclear receptor. Htun et al. presented the distinct sub- nuclear localization of agonist-bound, as opposed to antagonist-bound GR and suggested a functionally distinct subnuclear population [18] . In contrast, the clusters of GR are reported to lack a relation to the site of active transcription [43] . The significance of the speckle or cluster formation including nuclear ERa is the ultimate question but requires cautious investigations. Before the exposure to ligands, GFP-ERa was distributed within the nuclei in a fine-grained or speckled pattern, and the size, number, or intensity of the fluorescence was not completely uniform in each cell, although all cells from a single cell line were treated similarly. The activity of the intake of the transgene and its expression cannot be unified in transient transfection, which is affected by the phase of the cell cycle [45] . In addition to the disparity of the amount of chimera protein produced from the transfected gene, the components of the matrix with a cell cycle-specific distribution, such as hnRNP [7] coexisting with GFP-ERa, may cause the diversity in the subnuclear distribution of GFPERa separate from the effect of the ligands. The strategy that the GFP-ERa chimera protein is consistently expressed in cells whose cycles are synchronized will lead to more precise explanation.
Treatment with ligands, E 2 or Tam, induced nuclear redistribution in some cells to a more punctate pattern compared with cases without ligands. Ligands may cause the change in the compartment factors bound to GFP-ERa, such as coactivators or corepressors, and may redistribute GFPERas. It is also possible that the ligand-inducible translocation of GFP-ERa to the site of the chromatin was engaged in transcription.
Tamoxifen, one of the selective estrogen modulators, exhibits estrogen agonist effects in many organs and is widely used in the treatment of breast cancer. However, it stimulates uterine tissue as an antagonist and activates the promotor possessing activating protein 1 element [39] . The partial antagonist, Tam, and physiological agonist, E 2 , differ in their function via ERa, but these two compounds did not reveal different translocations of GFP-ERa. Further investigation with various ligands or hormones is anticipated to elucidate the significance of the variety of the intracellular distribution of ERa.
In conclusion, we have made the real-time analysis of the GFP-ERa possible in a single living cell. Our study showed that the GFP-ERa restricted to the nucleus and ligands exposure changed the distributions of this chimera protein to a punctate pattern. This system of investigation will contribute to the explanation of the intracellular dynamics of ERa and the mechanism of transcription induced with ERa.
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